Variant report
Variant | esv3692871 |
---|---|
Chromosome Location | chr5:103961296-103975749 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NUDT12-5 | chr5:103966237-103966357 | ENSG00000251574 |
2 | lnc-NUDT12-5 | chr5:103966088-103966357 | ENSG00000251574 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs569307468 | chr5:103964894-103964895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs542945107 | chr5:103964935-103964936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557025551 | chr5:103964977-103964978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs326246 | chr5:103964988-103964989 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs185141178 | chr5:103965026-103965027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551776550 | chr5:103965060-103965061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs115083273 | chr5:103965062-103965063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs326245 | chr5:103965068-103965069 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs190034120 | chr5:103965186-103965187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542726118 | chr5:103966125-103966126 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs145268226 | chr5:103966146-103966147 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs117344219 | chr5:103966152-103966153 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs559332853 | chr5:103966163-103966164 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs191655422 | chr5:103966173-103966174 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs544619971 | chr5:103966177-103966178 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs147585933 | chr5:103966203-103966204 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs73200566 | chr5:103966205-103966206 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs326244 | chr5:103966221-103966222 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs326243 | chr5:103966248-103966249 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs142100517 | chr5:103966274-103966275 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs183059881 | chr5:103966296-103966297 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs571618626 | chr5:103966340-103966341 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs35085811 | chr5:103966343-103966344 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs568053056 | chr5:103966347-103966348 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs576789032 | chr5:103970612-103970613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs73775469 | chr5:103970619-103970620 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs533428901 | chr5:103970625-103970626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs532395534 | chr5:103970633-103970634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546023741 | chr5:103970663-103970664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs529326767 | chr5:103970670-103970671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs549165768 | chr5:103970676-103970677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs72780797 | chr5:103970684-103970685 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs139807735 | chr5:103970690-103970691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547600671 | chr5:103970720-103970721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570690541 | chr5:103970732-103970733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539744257 | chr5:103970752-103970753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs145219025 | chr5:103970796-103970797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs326240 | chr5:103970812-103970813 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs181753302 | chr5:103970899-103970900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs142091282 | chr5:103970966-103970967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
Obesity | 20622171 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:103964800-103965200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
2 | chr5:103970600-103971000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |